ZERO - The End of Prostate Cancer
 

View Online

Donate

 

Will You Be One of ZERO's 50 Vets in 50 States?

50 Vets in 50 States

On Veteran's Day, ZERO launched a brand new campaign called "50 Vets in 50 States" – this campaign aims to bring faces and names to the many Veterans across the country that are battling prostate cancer – and we want you to be a part of it!

We are looking for a Veteran to represent each state! If you're a Veteran and a prostate cancer patient or survivor who is willing to be a vocal advocate and champion for men, we want you to join us:

  • Help raise awareness around the increased risk of prostate cancer for Veterans and military servicemen
  • Advocate for prostate cancer policies that would improve care for Vets at the state and federal level
  • Inform providers and patients about care options via the Mission Act

To get involved with the campaign, email Ali Manson, ZERO's VP of Government Relations and Advocacy.

Learn More About This Campaign
dividing line

Open Enrollment is Here, Enroll in 2021 Coverage Today!

Financial Resources

Important financial deadlines are fast approaching, with open enrollment for 2021 healthcare coverage available now. Open Enrollment is the yearly opportunity to sign up for benefits or make changes to your healthcare coverage. You have until December 15 to apply for new 2021 health insurance, or renew, change, or update your 2020 health plan for 2021, or December 7 if you’re enrolling for health or drug plans via Medicare.

Coverage starts January 1, 2021, and it’s easy to start or update an application at healthcare.gov, so get started today! Register ASAP because if you miss the deadline, the only way you’ll be eligible to enroll in or change your health plan for 2021 is if you qualify for a Special Enrollment Period.

If you are a prostate cancer patient and have questions about open enrollment or need assistance, call the toll-free ZERO360 comprehensive patient support hotline at (844) 244-1309.

Healthcare.gov Open Enrollment
dividing line

We're HAIR to Help: Grow & Give

Beard up. Speak Out. Let's do some good.

ZERO's scruffy superfriends are rocking and rolling with Grow & Give, already raising more than $66,000 to help men and families and spread awareness about prostate cancer this November. Wow!

Big shout out to our current leaderboard: Hops & Handlebars leads the community charge, Murrieta Police Department shows the boys in blue how it's done, and Boston Scientific blazes a trail across the corporate division. And of course, the incomparable Warren Macey is past and future king of the individual fundraisers. And big ups to our partner bros for always having our back.

Been sleeping on this year's no-shave campaign? It's never too late to beard up and help get patients the support they need while facing COVID-19. Bash the button and join us today!

Join Grow & Give
dividing line

Save the Date: Giving Tuesday is December 1!

#GivingTuesday logo

#GivingTuesday is the start of the holiday giving season, so every gift given on Tuesday, December 1, is DOUBLED! Gifts are especially critical right now, as patients are in desperate need of support due to the impacts of COVID-19. ZERO sincerely thanks our friends at Myriad Genetics for supporting our #GivingTuesday match effort. You can help maximize this gift match by creating a Facebook fundraiser now and spreading the word ahead of December 1.

Donate live and connect with the prostate cancer community during our #GivingTuesday all-day broadcast, starting at 6 a.m. Eastern on Facebook. Tune in to learn about ZERO’s impact and meet patients fighting prostate cancer during COVID-19 and staying #ZEROstrong during tough times.

Create a #GivingTuesday Fundraiser
dividing line

PET Scans & Prostate Cancer

Blue Earth Diagnostics PET Scan

Last year, my PSA levels spiked. My wife and I met with my doctor who said we would need to change my treatment to something more aggressive. We asked if there were any other options, and he mentioned that it could be a good time for a PET scan, and that maybe information gathered from nuclear imaging could help us come up with another treatment plan.

- John D., a patient living with recurrent prostate cancer

John's case is not unusual, and particularly at his stage of disease, nuclear medicine can sometimes be a helpful tool. Diagnostic radiopharmaceuticals can provide images of what is occurring inside the body at molecular and cellular levels. Depending on where the patient may be in the course of his disease, such a unique insight may enable physicians to personalize a patient's care.

Bring an information packet to your doctor to ask whether a PET scan might be right for you. (This content is provided in partnership with Blue Earth Diagnostics.)

dividing line

The Virtual ZERO Summit is Just Three Months Away!

Virtual Summit Conference

Are you excited for the first-ever Virtual ZERO Summit for Prostate Cancer?! In this brand new setting, you'll be able to connect with others, chat with experts, attend sessions on your own time, and access an awesome Summit app! Plus, the virtual format means that registration is FREE!

Don't miss the most impactful gathering in our community! Sign up today so you can be the first to be updated as new speakers are announced to our already awesome lineup, which includes Dr. Rachel Rubin on sexual health, and Dr. Stacey Loeb on prostate cancer myths.

And don't forget — nominations for the Impact Awards are still open for a few more days! You have until November 15 to nominate yourself or someone in the prostate cancer community who has made a positive impact on others through their efforts in advocacy, education, outreach, and more. Submit a worthy individual today!

Sign Up for the Summit
dividing line

Help more men receive genetic testing

Share what you know about genetic testing

1 in 6 men with prostate cancer inherited a gene mutation that may have caused their cancer. If a genetic test identifies you inherited a gene mutation, there is a 50% chance it will be passed down to your children. If you or your loved one have been affected by prostate cancer, take this short survey to share your insights. Your feedback will ensure other prostate cancer patients and their families receive better answers.

Start Survey Now

(This content is provided in partnership with Myriad Genetics.)

dividing line

Champions Corner

Tammy and Jeff Holbert

Raising Awareness, One Run/Walk at a Time

Tammy and Jeff Holbert are two ZERO Champions that prove that everything is bigger and BETTER in Texas! Notorious for attending all of the Texas and Oklahoma Run/Walk events two years in a row, the Holberts took their participation to a new level by completing a whopping 25 Virtual Run/Walks in 2020. This patient and caregiver duo have an incredible story to share about their journey to ZERO, and are always inspiring others! » See how Jeff and Tammy's Run/Walk fervor began

Twitch Streams

:pogchamp: for prostate cancer

Content Creators, Assemble!

Do you or someone you know have an audience on Twitch or similar websites? Do names like, "OBS," "StreamLabs," "Elgato," or "Xsplit" mean something to you? ZERO is branching out into the world of gaming and LiveStreaming, and we'd like to talk to you! » Email Jeremy for details

Webinars

ZERO360 Comprehensive Patient Support

Wednesday: Financial Resources Webinar

Join special guest speakers Monica Bryant, COO of Triage Cancer, and Jasmine Pugh, a ZERO360 Case Manager on Wednesday, November 18 at 6:30 p.m. (ET) for a webinar-discussion on prostate cancer patient support offerings like ZERO360, financial assistance, and more. » Register for free! (This webinar is sponsored by ZERO partner, Janssen Oncology.)

Annual Report

2019 Annual Report

See Your Successes of 2019!

See how your support, passion, and dedication in 2019 truly made a difference in the lives of men and families in our brand new annual report. It's only with your help that can ZERO continue to reach more at-risk men, and serve more patients. Flip through to see last year's major wins, and some familiar faces! » View the 2019 Annual Report

Clinical Trials

Patient image

Prostate Cancer Research Study

The TALAPRO-2 clinical trial is enrolling men with metastatic castration-resistant prostate cancer to study a potential treatment. More information is available. » Learn more (This content is provided in partnership with Pfizer Oncology.)

dividing line
 
Make sure you keep getting emails from ZERO. Add info@zerocancer.org to your address book or safe-sender list.
 
 

515 King Street
Suite 420
Alexandria, VA 22314
202-463-9455

view this email online

privacy policy

email preferences

 

 

This email was intended for

 

© 2025 ZERO – The End of Prostate Cancer. All rights reserved. ZERO is a 501(c)(3) non-profit organization.